Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) Sets New 52-Week High at $42.03

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTFGet Rating) hit a new 52-week high on Thursday . The company traded as high as $42.03 and last traded at $42.03, with a volume of 0 shares trading hands. The stock had previously closed at $42.03.

Separately, Deutsche Bank Aktiengesellschaft lowered their price objective on Recordati Industria Chimica e Farmaceutica from €47.00 ($48.96) to €44.00 ($45.83) and set a “hold” rating for the company in a research note on Monday, February 28th. One equities research analyst has rated the stock with a sell rating and four have given a hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $54.00.

The business has a fifty day simple moving average of $42.03 and a 200 day simple moving average of $55.87. The company has a market cap of $8.67 billion, a P/E ratio of 18.68 and a beta of 0.21.

Recordati Industria Chimica e Farmaceutica Company Profile (OTCMKTS:RCDTF)

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat.

Further Reading

Receive News & Ratings for Recordati Industria Chimica e Farmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Recordati Industria Chimica e Farmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.